Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a disorder of the pulmonary vasculature associated with elevated pulmonary vascular resistance. Despite recent advances in the treatment of PAH, with eight approved clinical therapies and additional therapies undergoing clinical trials, PAH remains a serious...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Urakami, Takeo, Järvinen, Tero A.H., Toba, Michie, Sawada, Junko, Ambalavanan, Namasivayam, Mann, David, McMurtry, Ivan, Oka, Masahiko, Ruoslahti, Erkki, Komatsu, Masanobu
Format: Artigo
Idioma:Inglês
Publicat: American Society for Investigative Pathology 2011
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123986/
https://ncbi.nlm.nih.gov/pubmed/21549345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.02.032
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars